UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3684-3684, Article 3684

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.23-40

2021

Link zum Volltext

Verfügbarkeit prüfen

Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population

International journal of cancer, 2011-05, Vol.128 (9), p.2182-2191

2011

Link zum Volltext

Verfügbarkeit prüfen

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1

Cell & bioscience, 2021-12, Vol.11 (1), p.217-217, Article 217

2021

Link zum Volltext

Verfügbarkeit prüfen

Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells

PloS one, 2012-12, Vol.7 (12), p.e51108

2012

Link zum Volltext

Verfügbarkeit prüfen

Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma

Journal of hepatology, 2016-06, Vol.64 (6), p.1256-1264

2016

Link zum Volltext

Verfügbarkeit prüfen

Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population

PloS one, 2011-05, Vol.6 (5), p.e19804-e19804

2011

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

Clinical cancer research, 2009-07, Vol.15 (13), p.4322-4335

2009

Link zum Volltext

Verfügbarkeit prüfen

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

Journal of hepatology, 2022-08, Vol.77 (2), p.383-396

2022

Link zum Volltext

Verfügbarkeit prüfen

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC

Hepatology (Baltimore, Md.), 2023-11, Vol.78 (5), p.1368-1383

2023

Link zum Volltext

Verfügbarkeit prüfen

Evidence of a novel docetaxel sensitizer, garlic‐derived S‐allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer

International journal of cancer, 2008-05, Vol.122 (9), p.1941-1948

2008

Link zum Volltext

Verfügbarkeit prüfen

C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway

Oncotarget, 2017-04, Vol.8 (14), p.23507-23516

2017

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of MSX2 in nodular hyperplasia, high‐grade prostatic intraepithelial neoplasia and prostate adenocarcinoma

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2010-12, Vol.118 (12), p.918-926

2010

Link zum Volltext

Verfügbarkeit prüfen

RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma

Journal of hepatology, 2021-02, Vol.74 (2), p.360-371

2021

Link zum Volltext

Verfügbarkeit prüfen

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma

Oncotarget, 2015-08, Vol.6 (25), p.20964-20976

2015

Link zum Volltext

Verfügbarkeit prüfen

Id-1 Induces Proteasome-dependent Degradation of the HBX Protein

Journal of molecular biology, 2008-09, Vol.382 (1), p.34-43

2008

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer

Oncogenesis (New York, NY), 2018-05, Vol.7 (5), p.44-12, Article 44

2018

Link zum Volltext

Verfügbarkeit prüfen

CDC25A Functions as a Novel Ar Corepressor in Prostate Cancer Cells

Journal of molecular biology, 2009-01, Vol.385 (2), p.446-456

2009

Link zum Volltext

Verfügbarkeit prüfen

Correction: Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population

PloS one, 2011-06, Vol.6 (6)

2011

Link zum Volltext

Verfügbarkeit prüfen

Reply to: ‘EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma’

Journal of hepatology, 2022-09, Vol.77 (3), p.880-882

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population

PloS one, 2011-06, Vol.6 (6)

2011

Link zum Volltext

Verfügbarkeit prüfen

EFNAs are functional predictors for overall survival of hepatocellular carcinoma patients

Journal of hepatology, 2022-05

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4778: Dissecting the gender disparity of hepatocellular carcinoma: roles of HBV X protein and androgen receptor

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4778-4778

2013

Link zum Volltext

Verfügbarkeit prüfen

Daxx regulates mitotic progression and prostate cancer predisposition

Carcinogenesis (New York), 2013-04, Vol.34 (4), p.750-759

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2431: EFNA3, a key functional mediator of hypoxic microenvironment in hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2431-2431

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(15)
Life Sciences & Biomedicine
(15)
Male
(12)
Cell Line, Tumor
(10)
Prostate Cancer
(8)
Tumors
(8)
Oncology
(7)
Animals
(6)
Hepatocellular Carcinoma
(6)
Aged
(5)
Carcinoma, Hepatocellular - Genetics
(5)
Gastroenterology & Hepatology
(5)
Liver Neoplasms - Genetics
(5)
Mice
(5)
Middle Aged
(5)
Antineoplastic Agents - Pharmacology
(4)
Biological And Medical Sciences
(4)
Blotting, Western
(4)
Carcinoma, Hepatocellular - Metabolism
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Gamma‐tocotrienol as an effective agent in targeting prostate cancer stem cell‐like population

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1

Inactivation of ATM/ATR DNA damage checkpoint promotes androgen induced chromosomal instability in prostate epithelial cells

Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma

Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population

Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC

Evidence of a novel docetaxel sensitizer, garlic‐derived S‐allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer

C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway

Differential expression of MSX2 in nodular hyperplasia, high‐grade prostatic intraepithelial neoplasia and prostate adenocarcinoma

RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma

Id-1 Induces Proteasome-dependent Degradation of the HBX Protein

Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer

CDC25A Functions as a Novel Ar Corepressor in Prostate Cancer Cells

Correction: Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population

Reply to: ‘EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma’

Correction: Chemopreventive Effect of PSP Through Targeting of Prostate Cancer Stem Cell-Like Population

EFNAs are functional predictors for overall survival of hepatocellular carcinoma patients

Abstract 4778: Dissecting the gender disparity of hepatocellular carcinoma: roles of HBV X protein and androgen receptor

Daxx regulates mitotic progression and prostate cancer predisposition

Abstract 2431: EFNA3, a key functional mediator of hypoxic microenvironment in hepatocellular carcinoma

Suchergebnisse filtern